• Facebook
  • X
  • Events
  • News
  • Donate
Search
Hit enter to search or ESC to close
New Jersey Alliance for Clinical and Translational Science New Jersey Alliance for Clinical and Translational Science
  • Home
  • About
    • Mission
    • Membership
    • Affiliated Institutions
    • NJ ACTS Leadership
    • Cite the CTSA and Publications
    • CTSA Resources
    • Elements
  • Community
    • Our Services
    • Community Leadership
    • Volunteering for a Clinical Trial FAQs
    • Find a Clinical Trial
    • Partnership & Innovation Funding Opportunities
    • COVID-19 Resources
  • Investigator Resources
    • Funding Opportunities
    • Biostatistics, Epidemiology, Research Design (BERD)
    • Informatics Services
    • Regulatory Knowledge & Support
    • Special Populations in Research
    • Team Science
    • Genetically informed Research, Education, And Treatment
    • Biomarkers
    • ResearchMatch (RM)
    • Dissemination & Implementation Workgroup
    • COVID-19
    • Additional Resources
  • Education & Training
    • Workforce Development
    • R25 Clinical Research Experiential Summer Training (CREST)
    • Badges
    • Seminars, Workshops, Media Library
    • Learning Health System – STAR
    • Promoting STEM in High School and Earlier
    • Undergraduate Education and Training
    • Beyond Traditional Graduate Courses
    • NJ ACTS Collaborative Graduate Programs
  • K12 & T32
    • K12 Mentored Career Development Awards
    • T32 Predoctoral Training Awards
  • Clinical Trials Office
    • About
    • OnCore
    • Solutions
    • Services
    • I want to start a clinical trial
    • Resources
  • Contact Us
    • NJ ACTS Newsletter
Select Page

Novel Approach for Educating Prison Populations About Medication for Opioid Use Disorder.

by William Jester | Sep 20, 2022 | Community, News

More than 90,000 people die of a drug overdose each year, with 75 percent of those involving an opioid, according to the Centers for Disease Control and Prevention. Although medication—buprenorphine, methadone or naltrexone—is an effective component in helping people...

No One-Size-Fits-All Artificial Intelligence Approach Works for Prevention, Diagnosis or Treatment Using Precision Medicine.

by William Jester | Sep 20, 2022 | Community, News

A Rutgers analysis of dozens of artificial intelligence (AI) software programs used in precision, or personalized, medicine to prevent, diagnose and treat disease found that no program exists that can be used for all treatments. “Precision medicine is one of the most...

Rutgers Study Indicates Who Faces Highest Risk of HPV Infection and Anal Cancer.

by William Jester | Sep 19, 2022 | Community, News

Previous sexually transmitted infections and more sexual partners predict new human papillomavirus (HPV) infections in men who have sex with men, other cisgender sexual minority men and transgender women, according to a Rutgers study. “Neither of those findings is...

VA Taps Rutgers Professor to Build Database Linking Veteran Ailments to Exposure From Burn Pits.

by William Jester | Sep 19, 2022 | Community, News

Scott Parrott, a Rutgers professor with more than 30 years of experience in methodology and statistics, will work with the U.S. Department of Veteran Affairs (VA) to create a database of evidence linking toxic exposure to burn pits to diseases such as...

Pfizer’s COVID pill Paxlovid has profound effect in seniors, jury still out for younger adults.

by William Jester | Sep 18, 2022 | Community, Covid, News

A new study is sure to add another layer of intrigue surrounding Pfizer’s COVID-19 pill Paxlovid. In the study, based on data collected from 109,000 patients at a large Israeli health system, the drug appeared highly effective in seniors. Researchers found that those...
« Older Entries
Next Entries »

Recent Posts

  • Join NJ ACTS Special Populations for a Seminar on 10/27
  • Join NCATS on 10/9 for the Director’s Roundtable
  • Mentoring Biomedical Graduate Students and Postdocs – Workshop 10/9
  • NJ ACS Community Event on 10/13 from 10:30 – 12:00
  • NJ ACTS Special Populations Seminar 9/29 – Register Now

Archives

  • 2026
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2025
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2024
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2023
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2022
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2021
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2020
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2019
    • December
    • November
    • October
    • September
    • August
    • July
    • June
    • May
    • April
    • March
    • February
    • January
  • 2018
    • December

Categories

  • Community (2,502)
  • Covid (1,001)
  • CTO Events (6)
  • News (3,179)
  • Pilots (21)
Rutgers R Block logo graphic

THIS SITE

About

Membership

Community

Investigator Resources

Education & Training

News

Events

Contact

CONTACT US

New Jersey Alliance For Clinical and Translational Science (NJ ACTS)

 


  • Facebook

  • Twitter

  • YouTube

  • LinkedIn

© 2019, New Jersey Alliance for Clinical and Translational Science (NJ ACTS). All rights reserved.| Privacy Policy

Rutgers, The State University of New Jersey, is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers web sites to accessibility@rutgers.edu or complete the Report Accessibility Barrier or Provide Feedback Form.